Inventor · disambiguated record
William L. Smith
Also filed as: SMITH WILLIAM · SMITH WILLIAM L · SMITH WILLIAM LORNE
18 granted patents·6 pending applications·1,180 citations·filing 1983–2023
96Inventor score
Top patents by PatentIndex Score
24 records- 0197US6037346ALocal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunctionVIVUS INC·Filed 1998·Granted Mar 14, 2000·224 cites·94 claims
- 0295US6403597B1Administration of phosphodiesterase inhibitors for the treatment of premature ejaculationVIVUS INC·Filed 2001·Granted Jun 11, 2002·166 cites·94 claims
- 0394US6127363ALocal administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunctionVIVUS INC·Filed 1999·Granted Oct 3, 2000·136 cites·106 claims
- 0494US5202333ATricyclic 5-HT3 receptor antagonistsSYNTEX INC·Filed 1991·Granted Apr 13, 1993·153 cites·50 claims
- 0592US6156753ALocal administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunctionVIVUS INC·Filed 1999·Granted Dec 5, 2000·113 cites·67 claims
- 0691US5922341ALocal administration of pharmacologically active agents to treat premature ejaculationVIVUS INC·Filed 1997·Granted Jul 13, 1999·102 cites·80 claims
- 0787US6548490B1Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunctionVIVUS INC·Filed 1999·Granted Apr 15, 2003·54 cites·51 claims
- 0887US6228864B1Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculationVIVUS INC·Filed 1998·Granted May 8, 2001·68 cites·18 claims
- 0986US5192770ASerotonergic alpha-oxoacetamidesSYNTEX INC·Filed 1990·Granted Mar 9, 1993·65 cites·34 claims
- 1078US10195249B2Activin-ActRII antagonists and uses for treating bone and other disordersCELGENE CORP·Filed 2013·Granted Feb 5, 2019·5 cites·16 claims
- 1175US4863919AMethod of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanesROBINS CO INC A H·Filed 1988·Granted Sep 5, 1989·19 cites·19 claims
- 1270US4717563A2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugsROBINS CO INC A H·Filed 1986·Granted Jan 5, 1988·16 cites·13 claims
- 1370US2023293634A1Activin-actrii antagonists and uses for treating bone and other disordersCELGENE CORP·Filed 2023·Application pending·0 cites
- 1466US5202318ATricyclic compounds acting at serotonin receptor subtypesSYNTEX INC·Filed 1991·Granted Apr 13, 1993·10 cites·52 claims
- 1560US4547514AAryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activityROBINS CO INC A H·Filed 1983·Granted Oct 15, 1985·10 cites·21 claims
- 1656US6037360AAdministration of 5-HT3 receptor antagonists to treat premature ejaculationVIVUS INC·Filed 1997·Granted Mar 14, 2000·16 cites·23 claims
- 1756US4857553AMethod of treating nausea and vomiting with certain substituted-phenylalkylamino (and aminoacid) derivatives and other serotonin depleting agentsROBINS CO INC A H·Filed 1988·Granted Aug 15, 1989·19 cites·22 claims
- 1852US2019262423A1Activin-actrii antagonists and uses for treating bone and other disordersCELGENE CORP·Filed 2019·Application pending·0 cites
- 1952US2003134861A1Transmucosal phosphodiesterase inhibitors for the treatment of erectile dysfunctionFiled 2003·Application pending·0 cites
- 2049US2002004498A1Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunctionFiled 2001·Application pending·0 cites
- 2146US2001008896A1Administration of active agents, including 5-HT receptor agonists and antagonists, to treat premature ejaculationFiled 2001·Application pending·0 cites
- 2245US2022120424A1Surge immune versatile terminal block assemblySMITH WILLIAM LORNE·Filed 2021·Application pending·0 cites
- 2341US4722834AMethod of using 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide-N-oxides to control emesis caused by anticancer drugsROBINS CO INC A H·Filed 1986·Granted Feb 2, 1988·4 cites·28 claims
- 2434US11813308B2Treatment of cardiovascular disease using ActRII ligand trapsCELGENE CORP·Filed 2015·Granted Nov 14, 2023·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when William L. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →